APR 18, 2024
New Concepts in Atrophy and Fibrosis in Neovascular AMD
Retina Subspecialty Day 2023
Retina/Vitreous
In this presentation from Retina Subspecialty Day 2023, Dr. Sadda discusses some suboptimal outcomes after anti-VEGF therapies for neovascular AMD, notably loss of vision from atrophy and fibrosis, and reviews new and upcoming treatments.